“…Approximately 4% to 10% of healthy individuals do not develop an adequate immune response against the hepatitis B vaccine after the primary vaccination series (18,19), and as reported in previous studies, nonresponsiveness was higher in patients with certain chronic illnesses such as chronic liver disease, uremia, inflammatory bowel disease, and CD (8–14,20–23).…”